Charles Brandes acquired 1.82 Million MerckInc shares worth $147 Million. That's 1.43% of their equity portfolio (23rd largest holding). The first MerckInc trade was made in Q1 2013. Since then Charles Brandes bought shares eighteen more times and sold shares on 30 occasions. The stake costed the investor $113 Million, netting the investor a gain of 31% so far.